Cetuximab treatment reduced in vivo tumor growth and weight (Figure 6A and B) and led to a trend of uPA expression reduction within the tumor tissue (Figure 6C), whereas TM expression was unaffected by in vivo cetuximab treatment (Figure 6D). This evidence concerns the gene PLAU and neoplasm.